Monographie - Teicoplanine - Stabilis 4.0

Siste oppdatering :
19/11/2024

Antibiotika

Teicoplanine

Injeksjon

Oppløsningsstabilitet

Stabilitet i blandinger

Faktorer som påvirker stabiliteten

Kompatibilitet

Administrasjonsmåte

Referanser

pdf

Kjemisk struktur

Handelsnavn

Handelsnavn

Handelsnavn er veiledende og sammensetning av hjelpestoffer kan være forskjellig avhengig av land og produsent

Bactomax	Brasil
Celplanin	India, Peru, Østerrike
Heptacidin	Mexico
Koplan	Brasil
Pitil	Chile
Plavital	Mexico
Sinbaken	Mexico
Targocid	Argentina, Australia, Belgia, Brasil, Chile, Colombia, Danmark, De forente arabiske emirater, Egypt, Finland, Frankrike, Hellas, Iran, Irland, Kroatia, Luxembourg, Malaysia, Marokko, Mexico, Nederland, New Zealand, Norge, Polen, Portugal, Slovenia, Spania, Storbritannia, Sveits, Sverige, Thailand, Tunisia, Tyrkia, Ungarn, Østerrike
Targosid	Italia, Portugal
Teicoplanin	Iran, Tyskland
Teicoplanina	Chile, Mexico, Spania
Teicox	Argentina
Tekosit	Tyrkia
Tepladex	Mexico
Teriplax	Mexico
Ticocin	Venezuela
Zicoplanin	India

Referanser

Injeksjon

Referanser : Teicoplanine

	Type	publikasjon
289	Journal	Jim LK. Physical and chemical compatibility of intravenous ciprofloxacin with other drugs. Ann Pharmacotherapy 1993 ; 27: 704-707.
1608	Journal	Galanti LM, Hecq JD, Jeuniau P, Vanbeck D, Jamart J. Assessment of the stability of teicoplanin in intravenous infusions. Int J Pharm Compound 2001 ; 5: 397-400.
2057	Journal	Droste JC, Jeraj HA, MacDonald A, Farrington K. Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis. J Antimicrob Chemother 2003 ; 51: 849-855.
2450	Journal	Manduru M, Fariello A, White RL, Fox JL, Bosso JA. Stability of ceftazidime sodium and teicoplanin sodium in a peritoneal dialysis solution Am J Health-Syst Pharm 1996 ; 53: 2731 - 2734.
3656	Labratorium	Teicoplanine (Targocid®) - Résumé des caractéristiques du produit Sanofi Aventis France 2014
3728	Journal	Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B. Visual compatibility of defibrotide with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2014 ; 71: 1288-1291.
3976	Journal	Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B. Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration. Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218
4440	Journal	Omotani S, Aoe M, Esaki S, Nagai K, Hatsuda Y, Mukai J, Teramachi H, Myotoku M. Compatibility of Intravenous Fat Emulsion with Antibiotics for Secondary Piggyback Infusion. Ann Nutr Metab 2018 ; 73: 227-233.
4444	Journal	Tounian P, Jehl F, Pauliat S, Morgant G, Ghirardi L, Selva M.A, Fontaine J.L, Aymard P, Girardet J.P. Stability and compatibility of Teicoplanin in parenteral nutrition solutions used in pediatrics. Clinical Nutrition 1999 ; 19, 3: 159-165.

Mentions Légales